Form D · Other Health Care
Metabiota, Inc.
San Francisco, CA · CIK 0001595047
Offering snapshot reported May 21, 2015 · SEC filing
- Reported sold
- $30.2M Offering amount: $30.2M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Dec 23, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 21, 2015 | Initial | $30,199,999 | No comparison | 24 | SEC filing |
| Mar 20, 2014 | Initial | $2,380,585 | No comparison | 12 | SEC filing |
| Dec 24, 2013 | Initial | $1,050,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-240303
Source: Form D, filed May 21, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeremy Alberga | Executive |
| John De Loche | Director |
| Robert Mann | Director, Executive |
| Riaz Valani | Director |
| Nathan D Wolfe | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
One Sutter, Suite 600
San Francisco, CA, 94104
San Francisco, CA, 94104